Cargando…
Treatments for COVID-19: Lessons from 2020 and new therapeutic options
To face the COVID-19 pandemic, prophylactic vaccines have been developed in record time, but vaccine coverage is still limited, accessibility is not equitable worldwide, and the vaccines are not fully effective against emerging variants. Therefore, therapeutic treatments are urgently needed to contr...
Autores principales: | Salasc, Fanny, Lahlali, Thomas, Laurent, Emilie, Rosa-Calatrava, Manuel, Pizzorno, Andrés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598952/ https://www.ncbi.nlm.nih.gov/pubmed/34915400 http://dx.doi.org/10.1016/j.coph.2021.11.002 |
Ejemplares similares
-
Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
por: Pizzorno, Andrés, et al.
Publicado: (2019) -
In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses
por: Checkmahomed, Liva, et al.
Publicado: (2020) -
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2
por: Pizzorno, Andrés, et al.
Publicado: (2020) -
Influenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infection
por: Pizzorno, Andrés, et al.
Publicado: (2018) -
Montelukast: The New Therapeutic Option for the Treatment of Epilepsy
por: Tesfaye, Bekalu Amare, et al.
Publicado: (2021)